Saturday, October 31, 2026

Philippines: Economy Expected to Plummet Further Amid COVID-19

Janess Ann Ellao

March 31, 2020

People wearing masks in the Philippines amid the coronavirus epidemic. (Photo by Vaticanews)

MANILA, Philippines (Via News) – Considered as the “worst shock” to the Philippine economy since the global crisis a decade ago, the economy here is set to suffer more disruptive impacts as its central bank foresees a massive slowdown in its economic growth as the country continues to combat the spread of COVID-19.

The government of this archipelagic country has imposed a lockdown in the whole of its biggest island – Luzon, where its capital Manila and its neighboring well-off cities are to be found. This, its central bank said, “could further dampen domestic economic activity."

As of this writing, the health department here has reported at least 2084 confirmed cases, with death toll pegged at 88. Critics have been demanding mass testing but the Philippine government remains adamant on pursuing a militarist approach by deploying military and police forces on the ground to supposedly keep peace and order amid the so-called enhanced community quarantine.

Globally, governments are working hard to mitigate the impacts of COVID-19 on their respective economies – with a former White House adviser saying that the “near standstill” economy, particularly in the US, may lead to a repeat of the Great Depression.

This will likely hurt smaller economies like the Philippines even more.

No less than the head of the Philippines’ finance department said in news reports that the government is likely to get a $1.8 million decrease in its tax collections. Still, he said the massive infrastructure spending – the cornerstone of the Duterte administration’s economic program – will continue despite critics saying that the country’s economic growth has been at its slowest in the past years.

Before the COVID-19, independent thinktank Ibon Foundation has long said that the continuing neglect of the country’s manufacturing and agriculture sector is behind the slow economic growth in the country. Citing government data, the group noted that the annual job generation, too, is considered as “lowest” in six decades, with only 81,000 in 2017.

On the ground, Ibon Foundation said the impacts of COVID-19 will likely affect at least 14 million families, who mostly have low income and “little savings if any.” The group estimates that about 5.2 million of these households “face the greatest difficulties amid the lockdown and severe disruption to their mobility and economic activity.”

So far, the Philippine government’s economic relief offered is a P27.1-billion response fund, the majority of which will be allocated to boost the tourism industry.

Meanwhile, the Philippine central bank is optimistic that the economy may be able to bounce back by 2021.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com